(Q44149588)

30 November 2017

Destruction of cultivated melanoma cells by lymphocytes from healthy black (North American Negro) donors (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

5 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790830

5 March 2023

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790830

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

5 March 2023

3

H O Sjögren

1 reference

30 November 2017

I. Hellström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790830

5 March 2023

K. E. Hellström

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790830

5 March 2023

G. A. Warner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790830

5 March 2023

language of work or name

English

0 references

publication date

1 January 1973

1 reference

30 November 2017

15 January 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4790830

full work available at URL

5 March 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910110113

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910110113

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

International Journal of Cancer

5 March 2023

published in

1 reference

30 November 2017

11

1 reference

30 November 2017

1

1 reference

30 November 2017

116-122

1 reference

Malignant melanoma in Uganda. (The relationship between pigmentation and malignant melanoma on the soles of the feet)

30 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910110113

Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular immunity to renal carcinomas in man

5 March 2023

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular and humoral immune responses to human urinary bladder carcinomas

5 March 2023

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cytotoxic lymphocytes in melanoma patients

5 March 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular immunity to nephroblastoma

5 March 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular and humoral immunity against human malignant melanoma

5 March 2023

6

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to moloney sarcomas

5 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular and Humoral immunity to Different Types of Human Neoplasms

5 March 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Demonstration of cell-mediated immunity to human neoplasms of various histological types

5 March 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

5 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

5 March 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular Immunity Against Tumor Antigens

5 March 2023

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Immunological Enhancement as Studied by Cell Culture Techniques

5 March 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Immunity to Neuroblastomas and Melanomas

5 March 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique

5 March 2023

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

5 March 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

5 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

Immunological studies on urinary bladder tumors of rats and mice

5 March 2023

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110113

5 March 2023

Identifiers

1 reference

30 November 2017

1 reference